BiotechTube
Home/Draig Therapeutics/Douglas E. Williams, Ph.D.
DE

Douglas E. Williams, Ph.D.

Chair of the Board of Directors

Draig Therapeutics

Therapeutic Areas

NeuropsychiatryMajor Depressive Disorder

Draig Therapeutics Pipeline

DrugIndicationPhase
DT-101Major Depressive Disorder (MDD)Phase 2
GABA-A Receptor ModulatorsUndisclosed Neuropsychiatric DisordersPreclinical

Leadership Team at Draig Therapeutics

IM
Ivana Magovčević-Liebisch
President and Chief Executive Officer
View full Draig Therapeutics profile